Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06483230 · ClinicalTrials.gov registry record · NA
Implementation of IVS3 for Upper Limb Motor Recovery
A NA study of Motor Activity and Stroke, Cardiovascular, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06483230: Recruiting NA study of Motor Activity and Stroke, Cardiovascular, sponsored by Weill Medical College of Cornell University.
NCT06483230 is a NA study of Motor Activity and Stroke, Cardiovascular that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 25 participants, below the 76-participant average among 6 other Motor Activity trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06483230, a NA study of Motor Activity and Stroke, Cardiovascular, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This study measures participant satisfaction and upper extremity function in outpatients with chronic stroke when exposed to the IVS3 device. Investigators hypothesize that treatment with the IVS3 device will be feasible and tolerable for use in the outpatient setting.
Primary Outcome
The primary outcome measure is defined as the mean number of sessions attended of the planned twelve visits. Min 0, Max 12.
Conditions Studied
Interventions
- DEVICE Intensive Visual Stimulation Device
Study Locations (1)
New York
- Weill Cornell Medicine, 525 E. 68th St, Baker Pavilion, F-2106 - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2024-10-02 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT06483230 shows while recruiting
NCT06483230 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 76-participant average among 6 other Motor Activity trials with a reported enrollment target (67% lower).
The record links to 4 conditions, with Motor Activity appearing as the primary indexed condition, and to 1 intervention - of which Intensive Visual Stimulation Device is the first listed.
NCT06483230 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06483230 about?
NCT06483230 is a clinical study titled "Implementation of IVS3 for Upper Limb Motor Recovery". This study measures participant satisfaction and upper extremity function in outpatients with chronic stroke when exposed to the IVS3 device. Investigators hypothesize that treatment with the IVS3 device will be feasible and tolerable for use in the outpatient setting.
What is the current status of trial NCT06483230?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-10-02. Estimated completion is 2027-06.
What conditions does trial NCT06483230 study?
This clinical trial studies the following conditions: Motor Activity, Stroke, Cardiovascular, Neglect, Hemispatial, Mirror Movement.
What interventions are being tested in trial NCT06483230?
The interventions under investigation include: Intensive Visual Stimulation Device (DEVICE).
Who is sponsoring clinical trial NCT06483230?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06483230 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Motor Activity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cranberry Polyphenols and Stress Resilience During Multitasking in Healthy Adults
RECRUITING · NA
-
Modulation of Motor Learning Via tDCS in a Dexterous Video Game Task
RECRUITING · NA
-
Unilateral M1 Anodal tDCS to Enhance Learning in a Gross Movement Videogame Task
ACTIVE NOT RECRUITING · NA
-
Fit Physicians: Use of Activity Monitors and Activity Integration Program in First Year Medical Students
COMPLETED · NA
-
Noninvasive VNS to Facilitate Excitability in Motor Cortex
COMPLETED · NA
-
Transcranial Direct Current Stimulation for Post-stroke Motor Recovery
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI